As hypothesized, heparanase (Fig. 2E) and TLR4 inhibition resulted in reduced capacity of cancer cells to form spheroids, although heparan sulfate itself and TLR4 agonist increased this effect (Fig. 5A). Here, TLR4 is linked to cancer.